[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341081-105":59,"doc-detail-341081-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cystine-cored-diphenylalanine-appended-peptide-based-self-assembled-fluorescent-nanostructures-direct-redox-responsive-drug-delivery","Cystine-cored diphenylalanine appended peptide-based self-assembled fluorescent nanostructures direct redox-responsive drug delivery","","Redox-responsive hollow spherical assemblies were developed by self-assembly of disulfide-linked cysteine-diphenylalanine (SN) for intracellular, site-specific chemotherapeutic delivery that spares healthy cells. The fluorescent hollow spheres show intrinsic green emission, proteolytic stability, and biocompatibility, and enable real-time monitoring of intracellular entry. Disulfide bonds degrade selectively in cancer cells with elevated glutathione (GSH), driving GSH-dependent redox release of doxorubicin (Dox). SN-Dox achieved efficient drug encapsulation and markedly improved effective potency against breast cancer viability while triggering comparable DNA damage and apoptosis signaling.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cystine-cored-diphenylalanine-appended-peptide-based-self-assembled-fluorescent-nanostructures-direct-redox-responsive-drug-delivery/341081/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cystine-cored-diphenylalanine-appended-peptide-based-self-assembled-fluorescent-nanostructures-direct-redox-responsive-drug-delivery/341081.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the cystine-diphenylalanine system enable redox-responsive drug delivery?","Question",{"text":113,"@type":114},"Disulfide bonds in the SN-based hollow spheres undergo selective degradation in the presence of high glutathione (GSH) concentrations, common in cancer cells. This degradation drives redox-responsive release of the encapsulated drug.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What role does glutathione (GSH) play in the intracellular behavior of SN-Dox?",{"text":118,"@type":114},"GSH levels in cancer cells are higher, creating an intracellular reducing environment. The elevated GSH promotes disulfide bond cleavage, resulting in GSH-dependent drug release within cancerous cells.",{"name":120,"@type":111,"acceptedAnswer":121},"What advantages does SN-Dox provide for monitoring and therapeutic performance?",{"text":122,"@type":114},"SN-Dox offers intrinsic fluorescence for real-time monitoring of intracellular entry and drug release. It also shows improved effective concentration for compromising breast cancer cell viability compared with non-malignant cells, while triggering DNA damage signaling and apoptosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341081,1790170706,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","iScience  \nll  \nOPEN ACCESS  \nArticle  \nCystine-cored diphenylalanine appended peptidebased self-assembled ﬂuorescent nanostructures direct redox-responsive drug delivery  \nSuman Nayak, Kiran Das, Subramaniyam Sivagnanam, ..., Dinesh Kumar, Biswanath Maity, Priyadip Das  \n[bmaity28@gmail.com](bmaity28@gmail.com) (B. M.) [priyadipcsmcri@gmail.com](priyadipcsmcri@gmail.com)[ ](priyadipcsmcri@gmail.com)(P.D.)  \nHighlights  \nRedox-responsive hollow spheres enable intracellular site-speciﬁc drug delivery  \nElevated glutathione levels in cancer cells trigger the drug release.  \nFluorescent SN-Dox offers real-time intracellular monitoring of drug release.  \nSN-Dox exhibits lower effective concentration for breast cancer cell viability.  \nNayak et al., iScience 27, 109523  \nApril 19, 2024 ª 2024 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/](https://doi.org/10.1016/)[ ](https://doi.org/10.1016/)[j.isci.2024.109523](j.isci.2024.109523)  \niScience  \nll  \nOPEN ACCESS  \nArticle  \nCystine-cored diphenylalanine appended  \npeptide-based self-assembled ﬂuorescent nanostructures direct redox-responsive drug delivery  \nSuman Nayak,1,5 Kiran Das,2,5 Subramaniyam Sivagnanam, 1,5 Shyamvarnan Baskar, 1 Adele Stewart,4 Dinesh Kumar,3 Biswanath Maity,2,* and Priyadip Das 1,6,*  \nSUMMARY  \nFabrication of stimuli-responsive superstructure capable of delivering chemotherapeutics directly to the cancer cell by sparing healthy cells is crucial. Herein, we developed redox-responsive hollow spherical assemblies through self-assembly of disulﬁde-linked cysteine-diphenylalanine (SN). These ﬂuorescent hollow spheres display intrinsic green ﬂuorescence, are proteolytically stable and biocompatible, and allow for real-time monitoring of their intracellular entry. The disulﬁde bond facilitates selective degradation in the presence of high glutathione (GSH) concentrations, prevalent in cancer cells. We achieved efﬁcient encapsulation (68.72%) of the anticancer drug doxorubicin (Dox) and demonstrated GSH-dependent, redox-responsive drug release within cancerous cells. SN-Dox exhibited a 20-fold lower effective concentration (2.5 mM) for compromising breast cancer cell viability compared to non-malignant cells (50 mM). The ability of SN-Dox to initiate DNA damage signaling and trigger apoptosis was comparable to that of the unencapsulated drug. Our ﬁndings highlight the potential of SN for creating site-speciﬁc drug delivery vehicles for sustained therapeutic release.  \nINTRODUCTION  \nAdvancements in the design and generation of efﬁcient drug delivery systems have been driven by a demand for improved drug efﬁcacy and speciﬁcity with the goal of minimizing adverse side effects particularly for drugs like cancer chemotherapeutics with extremely narrow therapeutic indices.1–6 The clinical utility of nanomedicines comprising chemotherapeutic drugs encapsulated in nanoparticle-based drug delivery systems (NDDSs) such as liposomes or dendrimers demonstrates the feasibility of this approach.7–12 However, available NDDSs materials suffer from several limitations including poor intracellular uptake and ineffectual drug release at the disease site. In addition, the generation of a successful NDDSs-based nanomedicine also requires optimization of circulation time, organ accumulation, and binding capacity at a target cell. Notably, peptide-based self-assembled superstructures remain of particular interest due to their unmatched biocompatibility, tunable properties, biodegradability, natural propensity for cellular targeting, and ability to release encapsulated drug molecules in a controlled manner.13–15 The ability to control both the location and temporal pattern of drug release remains an attractive prospect in the development of nanomedicines. To this end, stimulus-responsive drug delivery platforms have been generated16, 17 that allow for controlled drug release in response to external (e. g., light, ultrasound, and magnetic ﬁeld17–20) or internal (","cbCaieuGnwDSSvBs","https://ap.wps.com/l/cbCaieuGnwDSSvBs","pdf",5762525,"English","# Highlights\n## Introduction\n## Summary","[{\"question\":\"How does the cystine-diphenylalanine system enable redox-responsive drug delivery?\",\"answer\":\"Disulfide bonds in the SN-based hollow spheres undergo selective degradation in the presence of high glutathione (GSH) concentrations, common in cancer cells. This degradation drives redox-responsive release of the encapsulated drug.\"},{\"question\":\"What role does glutathione (GSH) play in the intracellular behavior of SN-Dox?\",\"answer\":\"GSH levels in cancer cells are higher, creating an intracellular reducing environment. The elevated GSH promotes disulfide bond cleavage, resulting in GSH-dependent drug release within cancerous cells.\"},{\"question\":\"What advantages does SN-Dox provide for monitoring and therapeutic performance?\",\"answer\":\"SN-Dox offers intrinsic fluorescence for real-time monitoring of intracellular entry and drug release. It also shows improved effective concentration for compromising breast cancer cell viability compared with non-malignant cells, while triggering DNA damage signaling and apoptosis.\"}]","Cystine-cored diphenylalanine appended peptide-based self-assembled fluorescent nanostructures direct redox-responsive drug delivery | PDF",1790040203,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/838999420cad4ce1d250045162172e79.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42eff5684ea0660f3fc80d15996d014a.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d7e7cbbfa2c60f162d30f962bffb301.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da3b23e1d91a7f12ac06ca5daf5e75ca.webp",980,1272]